Torrent Pharmaceuticals Ltd — Sorafenib Exporter Profile
Indian Pharmaceutical Exporter · #1 for Sorafenib · $600.0K export value · DGFT Verified
Torrent Pharmaceuticals Ltd is the #1 Indian exporter of Sorafenib with $600.0K in export value and 12 verified shipments. Torrent Pharmaceuticals Ltd holds a 3.6% market share in Sorafenib exports across 2 countries.
Torrent Pharmaceuticals Ltd — Sorafenib Export Profile: Buyers & Destinations
Where Does Torrent Pharmaceuticals Ltd Export Sorafenib?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $600.0K | 12 | 100.0% |
| BRAZIL | $3 | 1 | 0.0% |
Torrent Pharmaceuticals Ltd exports Sorafenib to 2 countries. The largest destination is UNITED STATES accounting for 100.0% of Torrent Pharmaceuticals Ltd's Sorafenib shipments. These destinations reflect Torrent Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sorafenib from Torrent Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TORRENT PHARMA INC | UNITED STATES | $400.0K | 8 |
| TORRENT PHARMA INC, | UNITED STATES | $200.0K | 4 |
| TORRENT DO BRASIL LTDA,, | BRAZIL | $3 | 1 |
Torrent Pharmaceuticals Ltd supplies Sorafenib to 3 buyers globally. The largest buyer is TORRENT PHARMA INC (UNITED STATES), followed by TORRENT PHARMA INC, (UNITED STATES) and TORRENT DO BRASIL LTDA,, (BRAZIL). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sorafenib Export Value and How Much Does Torrent Pharmaceuticals Ltd Contribute?
India exported $1.9M worth of Sorafenib through 916 shipments from 203 suppliers to 98 countries, serving 341 buyers globally. Torrent Pharmaceuticals Ltd contributes $600.0K to this total, accounting for 3.6% of India's Sorafenib exports. Torrent Pharmaceuticals Ltd ships Sorafenib to 2 countries through 3 buyers.
What Is the Average Shipment Value for Torrent Pharmaceuticals Ltd's Sorafenib Exports?
Torrent Pharmaceuticals Ltd's average Sorafenib shipment value is $50.0K per consignment, based on 12 shipments totaling $600.0K. The largest destination is UNITED STATES (100.0% of Torrent Pharmaceuticals Ltd's Sorafenib exports).
How Does Torrent Pharmaceuticals Ltd Compare to Other Indian Sorafenib Exporters?
Torrent Pharmaceuticals Ltd ranks #1 among 203 Indian Sorafenib exporters with a 3.6% market share. The top 3 exporters are NATCO PHARMA LIMITED ($850.0K), TORRENT PHARMACEUTICALS LTD ($600.0K), MEDYRA PHARMACEUTICAL ($162.4K). Torrent Pharmaceuticals Ltd processed 12 shipments to 2 destination countries.
What Sorafenib Formulations Does Torrent Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| SORAFENIB TABLETS USP 200MG 120S HDPE US(NDC 13668-682-12)(SORAFENIB 200MG) NOSSIZE 120'S TABLETS /BOTTLE | $200.0K | 4 |
| SORAFENIB TABLETS USP 200MG, 120S HDPE, US (NDC 13668-682-12)(SORAFENIB 200MG)(NOS=120'S TAB/BOTTLE)) | $150.0K | 3 |
| SORAFENIB TABLETS USP 200MG 120S HDPE US NDC 13668 682 12 SORAFENIB 200MG NOSSIZE 120 S TABLETS BOTTLE | $100.0K | 2 |
| SORAFENIB TABLETS USP 200MG 120S HDPE US | $50.0K | 1 |
| SORAFENIB TABLETS USP 200MG 120S HDPE USNDC 13668-682-12 SORAFENIB 200MG NOS = 120S TAB/BOTTLE | $50.0K | 1 |
| SORAFENIB TABLETS USP 200MG 120S HDPE USNDC 13668-682-12 NOS X 120S TAB/BOTTLE | $50.0K | 1 |
| Placebo of Sorafenib Tablets | $3 | 1 |
Torrent Pharmaceuticals Ltd exports 7 distinct Sorafenib formulations including tablets, capsules, syrups, and combination drugs. The top formulation is SORAFENIB TABLETS USP 200MG 120S HDPE US(NDC 13668-682-12)(S with 4 shipments worth $200.0K.
Regulatory Requirements: Exporting Sorafenib to Key Markets
What Torrent Pharmaceuticals Ltd must comply with to export Sorafenib to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Torrent Pharmaceuticals Ltd Compare to Nearest Sorafenib Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | NATCO PHARMA LIMITED | $850.0K | 17 | 4 | $50.0K |
| 1 | TORRENT PHARMACEUTICALS LTD ★ | $600.0K | 12 | 2 | $50.0K |
| 3 | MEDYRA PHARMACEUTICAL | $162.4K | 15 | 4 | $10.8K |
| 4 | HEET HEALTHCARE PRIVATE LIMITED | $76.4K | 34 | 9 | $2.2K |
Torrent Pharmaceuticals Ltd ranks #1 among 203 Indian Sorafenib exporters. Average shipment value of $50.0K compared to the market average of $9.3K. The closest competitors by value are NATCO PHARMA LIMITED and MEDYRA PHARMACEUTICAL.
Which Indian Ports Ship Sorafenib Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 245 | 26.7% |
| SAHAR AIR | 197 | 21.5% |
| DELHI AIR CARGO ACC (INDEL4) | 89 | 9.7% |
| Bombay Air | 69 | 7.5% |
| DELHI AIR | 68 | 7.4% |
| AHEMDABAD AIR | 37 | 4.0% |
| Bombay Air Cargo | 27 | 2.9% |
| AHEMDABAD AIR ACC (INAMD4) | 20 | 2.2% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sorafenib — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sorafenib shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Torrent Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 13 individual customs records matching Torrent Pharmaceuticals Ltd exporting Sorafenib, covering 7 formulations to 2 countries via 3 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 98+ countries, 341+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sorafenib Export Data from Torrent Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Torrent Pharmaceuticals Ltd's Sorafenib exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Torrent Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Sorafenib Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Torrent Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sorafenib. For current shipment-level data, contact TransData Nexus.